News – ��Ƶ

��Ƶ receives CE Mark for use of Versius in paediatric surgery

Jerome Vyland — Thu, 08 Jan 2026 07:00:30 +0000

��Ƶ, the global surgical robotics business, today announce that it has received CE and UKCA Marks for its Versius Surgical System (Versius) in paediatric surgery, marking the Company’s first regulatory clearance for treating children. The approval has been received for abdominal surgery in children and infants under the age of 18.

��Ƶ secures 510(k) clearance of its Versius Plus robotic surgical system

Jerome Vyland — Tue, 16 Dec 2025 17:20:46 +0000

��Ƶ, the global medical technology company, today announces its second-generation surgical robotic platform, Versius Plus, has received 510(k) clearance from the United States Food and Drug Administration (FDA) for cholecystectomy procedures.

��Ƶ Adopts NVIDIA IGX THOR for AI-Powered, Next Generation Surgical Robotics

Georgia Flack — Tue, 28 Oct 2025 18:30:42 +0000

View all press…

Source

Torbay and South Devon NHS Hospital welcome Versius into their surgical team

Georgia Flack — Wed, 24 Sep 2025 15:19:20 +0000

View all company…

Source

Nantes, France – 500 procedures performed by Versius

Georgia Flack — Wed, 24 Sep 2025 14:17:41 +0000

��Ƶ has closed a financing round of more than $200 million, backed by existing investors and new investor Trinity Capital

Chris O’Hara joins ��Ƶ as new Commercial President & General Manager – US

��Ƶ — Wed, 24 Sep 2025 12:51:48 +0000

View all press…

Source

��Ƶ secures more than $200M to accelerate growth

��Ƶ — Wed, 02 Apr 2025 06:00:37 +0000

��Ƶ has closed a financing round of more than $200 million, backed by existing investors and new investor Trinity Capital

Over 30,000 patients treated with Versius

��Ƶ — Wed, 19 Feb 2025 06:50:05 +0000

Versius—the second most utilised soft tissue surgical robot in the world—has now been used in over 30,000 surgical cases globally

��Ƶ and KEBOMED expand partnership to bring Versius to Sweden

��Ƶ — Thu, 06 Feb 2025 08:56:10 +0000

��Ƶ and KEBOMED expand existing partnership to include Sweden, so more patients can benefit from robotic-assisted minimal access surgery with Versius.

��Ƶ Appoints Massimiliano Colella as Chief Executive Officer

��Ƶ — Tue, 14 Jan 2025 07:00:54 +0000

��Ƶ announces the appointment of Massimiliano Colella as Chief Executive Officer and member of the Board of Directors.

News – ������Ƶ

������Ƶ receives CE Mark for use of Versius in paediatric surgery

������Ƶ secures 510(k) clearance of its Versius Plus robotic surgical system

������Ƶ Adopts NVIDIA IGX THOR for AI-Powered, Next Generation Surgical Robotics

Torbay and South Devon NHS Hospital welcome Versius into their surgical team

Nantes, France – 500 procedures performed by Versius

Chris O’Hara joins ������Ƶ as new Commercial President & General Manager – US

������Ƶ secures more than $200M to accelerate growth

Over 30,000 patients treated with Versius

������Ƶ and KEBOMED expand partnership to bring Versius to Sweden

������Ƶ Appoints Massimiliano Colella as Chief Executive Officer

News – ��Ƶ

��Ƶ receives CE Mark for use of Versius in paediatric surgery

��Ƶ secures 510(k) clearance of its Versius Plus robotic surgical system

��Ƶ Adopts NVIDIA IGX THOR for AI-Powered, Next Generation Surgical Robotics

Chris O’Hara joins ��Ƶ as new Commercial President & General Manager – US

��Ƶ secures more than $200M to accelerate growth

��Ƶ and KEBOMED expand partnership to bring Versius to Sweden

��Ƶ Appoints Massimiliano Colella as Chief Executive Officer